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Arterial stiffness has been established as a predictor of adverse 
cardiovascular outcome including stroke.1 The ambulatory 
arterial stiffness index (AASI) has been proposed as a meas-
ure that reflects arterial stiffness.2,3 Several studies have dem-
onstrated significant association of AASI with signs of target 
organ damage4,5 or with incidence of cardiovascular events.2,6,7 
AASI reflects the dynamic relationship between systolic and 
diastolic blood pressure during the day. AASI has been defined 
as unity minus the regression slope of diastolic divided by 
systolic blood pressure, as measured by ambulatory blood 
pressure monitoring.2,3 The stiffer the arterial tree, the closer 
the regression slope8 is to zero and the AASI is to unity. Until 
now, most previous studies relied on ambulatory blood pres-
sure monitoring to derive AASI. However, it is conceptually 
possible to calculate AASI by other techniques of blood pres-
sure measurement, which provide multiple measurements over 
a given period,9,10such as the self-measured blood pressure at 
home.9,10 Home blood pressure is currently widely used as an 
adjunct to office blood pressure for diagnosis and treatment of 
hypertension,11 and has a better prognostic value.11Automated 
techniques of self-measurement reduce observer bias and the 
white-coat effect.11 However, to our knowledge, no previous 
study has addressed the prognostic significance of the home 
arterial stiffness index (HASI). To address this question, to 
what extent HASI predicted stroke was investigated in Japanese 
subjects recruited from the population of Ohasama, Iwate 
Prefecture, Japan.
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BACKGROUND
Arterial stiffness is a stroke risk factor. The home arterial stiffness 
index (HASI) can be calculated from self-measured blood pressure 
using the same formula as the calculation of ambulatory arterial 
stiffness index (AASI).
METHODS
In 2,377 inhabitants (baseline age, 35–96 years) without a history 
of stroke, home blood pressure was measured once every morning 
for 26 days (median). HASI was defined as 1 minus the regression 
slope of diastolic over systolic on home blood pressure in individual 
subjects. The standardized hazard ratio (HR) of HASI was computed 
for cerebral infarction, while adjusting for sex, age, body mass 
index, pulse pressure, mean arterial pressure, heart rate, day-by-day 
variability of systolic blood pressure, smoking and drinking habits, 
serum total cholesterol, diabetes mellitus, and antihypertensive 
treatment.
RESULTS
A total of 191 (8.0%) cerebral infarctions and 75 (3.2%) hemorrhagic 
strokes occurred over a median of 13.8 years. Mean ± s.d. of HASI was 
0.60 ± 0.23 units. An increase in HASI of 1 s.d. was associated with an 
increased HR for cerebral infarction in all subjects (1.19, P = 0.034), 
men (1.37, P = 0.002), and normotensive subjects (1.46, P = 0.006), but 
not in women or hypertensive patients (P > 0.56). For hemorrhagic 
stroke, HASI was not prognostic.
CONCLUSIONS
HASI predicted cerebral infarction independent of pulse pressure and 
other risk factors in men and normotensive subjects. One important 
role of home blood pressure measurement is early recognition of 
onset of hypertension in normotensive subjects who are at risk of 
developing hypertension. HASI provides additional benefits for such 
subjects.
Keywords: AASI; blood pressure; epidemiology; HASI; hypertension; 
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METHODS
Study population. From 1988 until 1995, all 4,969 inhabit-
ants of Ohasama who were 35 years or older were contacted. 
Subjects who worked outside the town during the normal 
working hours of the study nurses (n = 1057), and those who 
were hospitalized (n = 166) or incapacitated (n = 94) were not 
eligible. Of the remaining 3,652 residents, 2,920 (80%) partici-
pated in the baseline examinations and agreed to follow-up. 
Subjects who had a previous history of stroke (n = 136) were 
excluded from the present analysis. An additional 407 sub-
jects were excluded from analyses because their home blood 
pressure measurements included less than ten readings (10 
days).12 Thus, the number of participants statistically  analyzed 
totaled 2,377.
All participants gave written informed consent. The 
Institutional Review Boards of Tohoku University School 
of Medicine and the Department of Health of the Ohasama 
Municipal Government approved the study. Information 
on demographic and socioeconomic characteristics of this 
region and the details of the protocol have been described 
previously.12
Collection of baseline data. Trained nurses collected anthro-
pometric data at public health centers. Body mass index was 
weight in kilograms divided by height in meters squared. 
Physicians and/or public health nurses instructed partici-
pants on how to perform home blood pressure measurements. 
Subjects were asked to measure blood pressure once every 
morning over a period of 4 weeks using an oscillometric device 
(HEM 401C; Omron Healthcare, Kyoto, Japan)13 within 1 h of 
waking up, with measurements performed in a sitting position 
after at least 2 min of rest.12 The average of all readings was 
defined as the home blood pressure and was used for analysis 
and diagnosis of hypertension. Hypertension was home blood 
pressure of at least 135 mm Hg systolic or 85 mm Hg diasto-
lic,11 or the use of antihypertensive drugs. HASI was computed 
for each individual using a modification of the procedure for 
derivation of AASI.2,3 From the home blood pressure read-
ings for each participant the regression slope of home diastolic 
divided by systolic blood pressure was computed using sim-
ple regression analysis.2,3 HASI9 was 1 minus the regression 
slope.2,3 The regression line was not forced through the origin 
(intercept = 0). The stiffer the arterial tree, the closer the regres-
sion slope and HASI are to 0 and 1, respectively.8 The square of 
the correlation coefficient between systolic and diastolic blood 
pressure was recognized as a measure of the “goodness of fit” 
of the AASI regression line.14 Using the same procedure, the 
“goodness of fit” of the HASI was calculated as the correlation 
coefficient of home systolic and diastolic blood pressure in each 
individual. In addition, from individual recordings and read-
ings used for HASI, pulse pressure was computed as the differ-
ence between the home systolic and diastolic blood pressures 
and mean arterial pressure as home diastolic blood pressure 
plus one third of the pulse pressure. Day-by-day variability 
of blood pressure was defined as the within-subject standard 
deviation of the home blood pressure readings.12
Study nurses administered a standardized questionnaire 
which included questions concerning each subject’s medi-
cal history, intake of medications, and smoking and drinking 
habits. Smoking was defined as the present use of tobacco,12 
and likewise drinking was defined as the current consump-
tion of alcoholic beverages.12 Previous cardiovascular disease 
included stroke, transient ischemic attack, coronary heart 
disease, and atrial fibrillation. Venous blood samples were 
analyzed by automated enzymatic methods for serum total 
cholesterol and blood glucose. Hypercholesterolemia was a 
serum cholesterol level of at least 5.68 mmol/l (220 mg/dl) or 
use of lipid-lowering drugs. Diabetes mellitus was defined as 
a fasting glucose level of ?7.0 mmol/l (?126 mg/dl), a random 
glucose level of ?11.1 mmol/l (?200 mg/dl), or the use of insu-
lin or oral antidiabetic drugs.15
Follow-up and outcomes. The ascertainment of outcomes and 
events has been described in detail previously.12 Vital status 
was ascertained until 31 May 2007 via the residents’ registra-
tion cards, which are required for payment of pension and 
social security benefits. The incidence of stroke was ascertained 
from the Stroke Registration System of Iwate Prefecture, death 
certificates, receipts of National Health Insurance, and ques-
tionnaires sent to each household. This was then confirmed by 
checking the medical records of Ohasama Hospital, which is 
the only hospital in the town and was where more than 90% 
of the subjects had their regular check-ups. The endpoints 
considered in the present analysis were stroke (ICD-10 codes 
I60–I69), cerebral infarction (ICD-10 code I63), and hemor-
rhagic stroke (ICD-10 codes, I60 and I61). Among participants 
who had multiple events, only the first event was considered 
for analysis.
Statistical analysis. For database management and statistical 
analysis, SAS software, version 9.1 (SAS Institute, Cary, NC) was 
used. Means and proportions were compared by the large-sam-
ple z test or ANOVA and the χ2-statistic, respectively. Statistical 
methods also included single correlation analysis. To explore the 
plausibility of the Cox model, first, incidence rates were plotted 
by tertiles of the HASI distributions. Standardized hazard ratios 
(HRs) of HASI were then calculated using multiple Cox regres-
sion while adjusting for baseline characteristics including sex, age, 
body mass index, pulse pressure, mean arterial pressure, heart 
rate, day-by-day variability of systolic blood pressure,12 smoking 
and drinking habits, serum total cholesterol, diabetes mellitus, 
and antihypertensive treatment. HASI was further accounted for 
(instead of pulse pressure) when analyzing HR of pulse pressure. 
Standardized HRs were used to express the risk per standard 
deviation increase in the explanatory variable. Differences in the 
predictive value of HASI across subgroups were tested by intro-
ducing the appropriate interaction terms in the Cox models.
RESULTS
Baseline characteristics
The 2,377 participants consisted of 1,454 (61.2%) women, and 
944 (39.7%) patients with hypertension, of whom 669 (70.9%) 
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were taking antihypertensive drugs. Mean ± s.d. were 58.9 ± 
12.2 years for age, 0.60 ± 0.23 units for HASI, and 0.53 ± 0.25 
for the within-subject correlation coefficients between home 
systolic and diastolic blood pressures. Compared to women, 
men had higher rates of smoking (18.0 vs. 1.4%, P < 0.0001), 
drinking (21.6 vs. 4.1%, P < 0.0001), and higher mean arterial 
pressure (95.1 ± 10.5 vs. 88.6 ± 10.3, P < 0.0001). The differ-
ences between women and men were not significant for mean 
age (59.1 ± 12.1 vs. 58.7 ± 12.3 years, P = 0.36), use of anti-
hypertensive drug treatment (17.9 vs. 10.2%, P = 0.12), preva-
lence of diabetes mellitus (5.3 vs. 4.0%, P = 0.19), and history of 
heart disease (0.4 vs. 0.3%, P = 0.93). HASI was similar among 
women and men (0.59 ± 0.26 vs. 0.60 ± 0.22, P = 0.10). On 
the contrary, HASI was higher in hypertensive patients than in 
normotensive subjects (0.64 ± 0.23 vs. 0.57 ± 0.24, P < 0.0001). 
The within-subject correlation coefficients between home 
systolic and diastolic blood pressure did not differ between 
women and men (0.52 ± 0.24 vs. 0.53 ± 0.27, P = 0.32), and 
between hypertensive patients and normotensive subjects 
(0.52 ± 0.26 vs. 0.53 ± 0.25, P = 0.58).
Table 1 lists the baseline characteristics of participants 
across thirds of the HASI distribution. In single correlation, 
HASI correlated positively with age (r = + 0.18; P < 0.0001), 
pulse pressure (r = + 0.30; P < 0.0001), mean arterial pressure 
(r = + 0.12; P < 0.0001), and day-by-day variability of systo-
lic blood pressure (r = + 0.04; P = 0.08). The number of read-
ings available per recording for the calculation of HASI, blood 
pressure level and blood pressure variability averaged 24.4. The 
50th, 25th, 10th, 5th, and 1st percentile values were 26, 22, 16, 
13, and 10, respectively.
Follow-up and outcome
The mean duration of follow-up was 13.2 ± 4.8 years (maxi-
mum 19.3). Of 2,377 study subjects, 78 were lost to follow-up. 
A first stroke occurred in 268 participants, which was due to 
cerebral infarction in 191, intracerebral hemorrhage in 57, 
subarachnoid hemorrhage in 18, and unknown causes in 2. 
In the entire study population, the incidence of cerebral inf-
arction tended to increase across thirds of HASI (4.1, 6.5, and 
7.7 infarctions per 1,000 subjects-years; trend P = 0.13). A log-
linear relationship was observed in men and in normotensive 
subjects (Figure 1).
Unadjusted HRs were computed for HASI and other blood 
pressure parameters (Table 2). In an adjusted model, these 
parameters, except for pulse pressure, also significantly pre-
dicted cerebral infarction in the overall study population. 
When systolic blood pressure and diastolic blood pressure were 
adjusted for instead of mean blood pressure and pulse pres-
sure (alternative adjusted model), the results were confirma-
tory with the exception of diastolic blood pressure (Table 2). 
Figure 2 also demonstrates the HR of HASI. The HR of HASI 
was significant in men (1.37, P = 0.002), and normotensive 
subjects (1.46, P = 0.006), but not in women, treated hyper-
tensive patients, or untreated hypertensive patients (P > 0.71). 
When hypercholesterolemia was adjusted for instead of serum 
total cholesterol, and for body height or weight instead of body 
Table 1 | Clinical characteristics across tertiles of the home arterial stiffness index (HASI)
HASI tertiles limits <0.50 0.50–0.68 ?0.68 P value
Number of subjects 792 793 792
Women, n (%) 460 (58.1) 495 (62.4) 499 (63.0) 0.090
Age, years 55.6 ± 11.3 60.3 ± 12.0 61.0 ± 12.4 <0.0001
Body mass index, kg/m2 23.3 ± 2.9 23.5 ± 2.9 23.6 ± 2.9 0.071
Home BP, mm Hg
 Systolic 119.6 ± 13.5 124.5 ± 15.4 128.3 ± 14.9 <0.0001
 Diastolic 74.1 ± 10.0 74.6 ± 9.7 75.2 ± 9.9 0.107
 Pulse pressure 45.4 ± 7.6 49.9 ± 10.3 53.1 ± 10.5 <0.0001
 Mean arterial pressure 89.3 ± 10.7 91.3 ± 10.8 92.9 ± 10.8 <0.0001
Home heart rate, beats/min 67.2 ± 7.9 67.4 ± 7.7 67.7 ± 7.7 0.454
Day-by-day systolic BP variability, mm Hg 8.2 ± 2.9 8.8 ± 3.2 8.7 ± 3.4 <0.0001
Current smokers, n (%) 176 (22.2) 146 (18.4) 137 (17.3) 0.034
Current drinkers, n (%) 162 (27.5) 160 (26.4) 140 (23.2) 0.215
Serum total cholesterol, mmol/l 5.0 ± 0.9 5.0 ± 0.9 5.0 ± 1.0 0.381
Hypercholesterolemia, n (%) 207 (26.1) 207 (26.1) 222 (28.3) 0.612
Diabetes mellitus, n (%) 72 (9.1) 83 (10.5) 64 (8.1) 0.257
Previous heart disease, n (%) 3 (0.4) 6 (0.8) 6 (0.8) 0.547
Antihypertensive drug treatment, n (%) 169 (21.3) 239 (30.1) 261 (33.0) <0.0001
Means and proportions were compared by ANOVA and the χ2-statistic, respectively. Values are mean ± s.d.. Day-by-day systolic BP variability was defined as the within-subject s.d. of 
home systolic blood pressure in the morning. Hypercholesterolemia was a serum cholesterol level of at least 5.68 mmol/l (220 mg/dl) or use of lipid-lowering drugs. Diabetes mellitus 
was a fasting glucose level of ?7.0 mmol/l (?126 mg/dl), a random glucose level of ?11.1 mmol/l (?200 mg/dl) or the use of insulin or oral antidiabetic drugs.
BP, blood pressure.
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mass index, the results were confirmatory. A significant or 
marginally significant interaction of the HR for cerebral inf-
arction was observed between men and women (P = 0.014), 
and between normotensive subjects and hypertensive patients 
(P = 0.056). However, the interaction between women and men 
dropped to a nonsignificant level after exclusion of patients on 
antihypertensive medication (P = 0.16). Then, we stratified the 
subject at age of 65, which was considered the beginning of 
elderly citizen, and pensionable age in Japan. Stratification by 
age group (<65 years, N = 1,604 vs. ?65 years, N = 773) did not 
significantly affect the associations of HASI and cerebral inf-
arction (P = 0.22 for interactions). For hemorrhagic stroke, the 
adjusted HRs for HASI were not significant (0.76?HR?1.34, 
P ? 0.12).
Table 2 | Hazard ratios for cerebral infarction according to the home arterial stiffness index (HASI) and related parameters at entry
Total Men Normotensives
Subjects, no. 2,377 923 1,433
End points, no. 191 93 56
Unadjusted
 HASI, units 1.38 (1.21–1.57)*** 1.48 (1.27–1.72)*** 1.59 (1.31–1.94)***
 Pulse pressure, mm Hg 1.89 (1.70–2.11)*** 1.97 (1.68–2.30)*** 3.21 (2.28–4.52)***
 Mean BP, mm Hg 1.89 (1.65–2.16)*** 1.86 (1.53–2.27)*** 1.94 (1.28–2.93)***
 Systolic BP, mm Hg 2.19 (1.92–2.50)*** 2.22 (1.83–2.69)*** 3.67 (2.27–5.94)***
 Diastolic BP, mm Hg 1.56 (1.36–1.78)*** 1.51 (1.23–1.85)*** 1.28 (0.89–1.84)
 Day-by-day systolic BP variability, mm Hg 1.67 (1.50–1.86)*** 1.68 (1.45–1.95)*** 1.65 (1.28–2.14)***
Adjusted
 HASI, units 1.19 (1.01–1.41)* 1.37 (1.12–1.67)*** 1.46 (1.12–1.90)**
 Pulse pressure, mm Hg 1.10 (0.93–1.30) 1.11 (0.86–1.40) 1.61 (1.02–2.56)*
 Mean BP, mm Hg 1.31 (1.10–1.56)*** 1.43 (1.12–1.81)*** 1.38 (0.83–2.29)
 Day-by-day systolic BP variability, mm Hg 1.23 (1.07–1.42)*** 1.26 (1.03–1.54)* 1.29 (0.95–1.76)
Alternative adjusted
 HASI, units 1.19 (1.01–1.41)* 1.37 (1.12–1.67)*** 1.46 (1.12–1.90)**
 Systolic BP, mm Hg 1.30 (1.02–1.65)* 1.36 (0.96–1.92) 2.38 (1.20–4.69)*
 Diastolic BP, mm Hg 1.08 (0.86–1.35) 1.13 (0.83–1.54) 0.76 (0.42–1.38)
 Day-by-day systolic BP variability, mm Hg 1.23 (1.07–1.42)*** 1.26 (1.03–1.54)* 1.29 (0.95–1.76)
Hazard ratios (95% confidence intervals) reflect the risk associated with a one standard deviation increase in the explanatory variables. Adjusted model accounted for sex, age, body mass 
index, heart rate, smoking and drinking habits, serum total cholesterol, diabetes mellitus, and antihypertensive treatment and included HASI, pulse pressure, mean arterial pressure, and 
day-by-day variability of systolic blood pressure. Alternative adjusted model further included systolic BP and diastolic BP instead of mean BP and pulse pressure.
*P ? 0.05; **P ? 0.01; ***P ? 0.005.
BP, blood pressure.
1
2
4
8
16
32
1
2
4
8
16
32
1
In
ci
de
nc
e 
of
 c
er
eb
ra
l in
fa
rc
tio
n,
pe
r 1
,0
00
 p
at
ie
nt
-y
e
a
rs
Men (N = 923)
P = 0.065
Women (N = 1454)
P = 0.35
Normotensives (N = 1433)
P = 0.081
Hypertensives, treated (N = 669)
P = 0.80
HASI, unitsHASI, units
36 38 35
8
17
23
30
40
23
37 38
Hypertensives, untreated (N = 275)
P = 1.00 
10
88
31
0.2 0.4 0.6 0.8 10.2 0.4 0.6 0.8
Figure 1 | Crude incidence of cerebral infarction in thirds of the distribution of the home arterial stiffness index (HASI) at entry in subgroups stratified by sex 
(left) and hypertension status (right). The ordinate has a logarithmic scale. Numbers represents the number of stroke occurred in each third. Hypertension was 
defined as a home blood pressure in the morning of at least 135 mm Hg systolic or 85 mm Hg diastolic, or as the use of antihypertensive drugs.
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Figure 3 shows 10-year absolute risk of cerebral infarction 
in normotensives in relation to home systolic blood pressure 
(left panel) at different levels of HASI and in relation to HASI 
(right panel) at different levels of home systolic blood pressure. 
Home systolic blood pressure and HASI were independent 
predictors of cerebral infarction in normotensives.
DISCUSSION
In the present study, HASI had a predictive value for cerebral 
infarction independent of pulse pressure. This finding was 
consistent with previous studies of AASI.2,6,7 In the Dublin 
Outcome Study, the AASI was a stronger predictor of stroke 
mortality than pulse pressure, with an opposite trend for car-
diac mortality.2 In the general population of Denmark, the 
standardized HR of AASI for stroke was 1.62 (P = 0.007), while 
that of pulse pressure did not reach statistical significance (P 
> 0.47) when the AASI and pulse pressure were forced into 
the model.7 Previous studies which investigated associations 
between stroke and blood pressure levels using conventional 
blood pressure16,17 and ambulatory blood pressure18 showed 
that pulse pressure was not very strongly associated with stroke. 
In relation to cerebral infarction, it has recently been observed 
that mean arterial pressure was more strongly associated with 
cerebral infarction than pulse pressure in 2,369 Ohasama resi-
dents aged ?35 years (mean, 59 years).19 Compared to mean 
arterial pressure, pulse pressure may not be important for 
prediction of cerebral infarction. The present result that HASI 
had no predictive value for hemorrhagic stroke was not sur-
prising. HASI is an index of arterial stiffness. However, hem-
orrhagic stroke is due to high blood pressure load rather than 
atherosclerosis.20
In line with recent cross-sectional studies,9,10 HASI was 
associated with age (r = + 0.18; P < 0.0001) and pulse pressure 
(r = + 0.30; P < 0.0001). These associations were comparable 
to those observed in studies of AASI.2,3,6,7,9,14 It has previously 
been observed that the correlation coefficient of AASI with age 
and with 24 h pulse pressure was 0.26 and 0.24, respectively, 
in the Ohasama population.6 In 7,604 subjects from six gen-
eral populations,14 AASI was correlated with age (r = + 0.37; 
P < 0.001) and 24 h pulse pressure (r = + 0.49; P < 0.0001). 
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Figure 3 | Ten-year absolute risk of cerebral infarction (no. of events 56) 
in normotensives (N = 1433) in relation to home systolic blood pressure 
(left) at different levels of HASI, and in relation to HASI (right) at different 
levels of home systolic blood pressure. The analyses were standardized 
to the distributions (mean or ratio) of sex, age, body mass index, diastolic 
blood pressure, heart rate, day-by-day variability of systolic blood pressure, 
smoking and drinking habits, serum total cholesterol, diabetes mellitus, and 
antihypertensive treatment (Alternative adjusted model in Table2). In left 
panel, the risk functions span the 5th–95th percentile interval of the home 
systolic blood pressure and correspond to the 5th, 25th, 50th, 75th, and 95th 
percentiles of HASI. In right panel, the risk functions span the 5th to 95th 
percentile interval of HASI and correspond to the 5th, 25th, 50th, 75th, and 
95th percentiles of the home systolic blood pressure. The P values for the 
independent effect were P = 0.006 for HASI and P = 0.013 for home systolic 
blood pressure. BP, blood pressure; HASI, home arterial stiffness index.
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Stergiou et al.9 directly compared HASI vs. AASI in 483 hyper-
tensive patients, and reported that the correlation coefficients 
of HASI with age and pulse pressure were less close than those 
of 24 h AASI (P < 0.001). Based on these findings, they con-
cluded that HASI appears to be similar but also has important 
differences from AASI. It is still uncertain whether HASI is a 
surrogate measure of AASI. However, given the link between 
HASI and cerebral infarction demonstrated in this study, HASI 
in itself is realistically important.
At this point, devices for home blood pressure measurement 
are produced worldwide at a rate of more than 10 million per 
year, and 30 million such devices have already been distributed 
in Japan, with most being purchased by the general public or 
patients themselves.21 One important role of home blood pres-
sure measurement is early recognition of the onset of hyper-
tension. For this aim, the main target of the measurement is 
normotensive subjects who are at risk of developing hyper-
tension. HASI provides additional benefits for these subjects. 
Conversely, ambulatory blood pressure monitoring is expen-
sive, and constitutes an excessive physical and mental load on 
patients. Therefore, for normotensive subjects, it would not 
be realistic to measure AASI. With similar reasons, measure-
ment of other stiffness parameters, such as pulse wave velocity 
and augmentation index, is also not suitable for normoten-
sive subjects. Among currently available stiffness parameters, 
only HASI has the potential to provide additional benefits for 
normotensive subjects in terms of feasibility. Presently, most 
home blood pressure devices at mainstream price points have 
a memory function for blood pressure readings. It would not 
be difficult for manufacturers to add a function of automated 
computation of HASI to home blood pressure device.
In regards to prediction of cerebral infarction, a distinct sex 
difference was found in HASI; however the predictive power 
was evident only in men but not women. Conversely, in rela-
tion to AASI, the standardized HRs of AASI for stroke tended 
to be higher in women than men.2,7 No previous prospec-
tive studies of AASI have reported that the predictive power 
of AASI was more pronounced in men than in women. The 
‘goodness of fit’ of the HASI regression line did not differ 
between women and men (0.52 ± 0.24 vs. 0.53 ± 0.27, P = 0.32) 
in the present study. Thus, the quality of measurement of HASI 
was comparable in women and men, at least in terms of the 
goodness of fit. In the present study, compared to women, men 
tended to have a lower rate of antihypertensive treatment (10.2 
vs. 17.9%, P = 0.12). Furthermore, the interaction of the HR 
for cerebral infarction between women and men dropped to 
a nonsignificant level after exclusion of patients on antihyper-
tensive medication (P = 0.16). Thus, difference in treatment 
rates between women and men might partly explain the sex 
difference seen in the predictive value of HASI. Other pos-
sible reasons why the predictive power of HASI was evident 
only in men but not women could have been that, compared 
to women, men showed a higher cardiovascular risk level in 
terms of smoking and drinking habits and their blood pressure 
level in the present study. However, even after adjustment of 
cardiovascular risk factors, the interaction term between men 
and women on the risk of cerebral infarction was still signifi-
cant (Figure 2). It was difficult to answer whether the sex dif-
ference seen in prognostic accuracy was specific for HASI or 
for the study population. Further studies are needed to assess 
the prognostic significance for stroke.
Several studies have reported the prognostic significance 
of AASI for nonfatal7 and fatal strokes,2,6,7 but not for cardiac 
events. These studies2,6,7 consistently demonstrated that AASI 
predicted stroke. In the Dublin Outcome Study2 and in a popu-
lation study in Copenhagen,7 AASI was a stronger predictor of 
stroke in normotensive subjects than in hypertensive patients. 
The present study supports these previous observations.2,7 
Indeed, the prognostic value of HASI was significant in nor-
motensive subjects (1.52, P = 0.0006), but not in hypertensive 
patients (P > 0.61). One possible explanation is that treatment 
to lower blood pressure might be a major confounder that 
weakens the association between the risk of stroke and HASI. 
In the present study, 70.9% of hypertensive patients were under 
antihypertensive medication. However, in untreated hyperten-
sive patients, HASI was not predictive of cerebral infarction. 
Hypertension is one of the major causes of stroke. Among 
patients with such a major risk factor, the impact of HASI 
on cerebral infarction may be relatively reduced. As seen in 
Figure 1, hypertensive patients (irrespective of receiving anti-
hypertensive medication) showed a much higher incidence of 
cerebral infarction compared to normotensive subjects, and 
were not affected by HASI. Thus, the prognostic significance 
of HASI may be limited to relatively healthy subjects. HASI 
may reflect mild or early atherosclerosis rather than advanced 
atherosclerosis.
The present study has several limitations. First, the present 
analysis was exclusively based on stroke, not on cardiac events. 
Second, middle-aged or older women made up the majority 
of the Ohasama participants. To some extent this imbalance 
in the age distribution might limit the generalizability of the 
current findings. Third, data on use of antiplatelet agents were 
not included. However, because of the low prevalence of his-
tory of heart disease (0.4%), the prevalence of patients taking 
antiplatelet agents is probably very small.
In conclusion, HASI derived from self-measurement of home 
blood pressure according to the same formula as the AASI was 
predictive of cerebral infarction independent of pulse pres-
sure, mean arterial pressure, and day-by-day blood pressure 
variability in men and normotensive subjects recruited from 
a Japanese population. However, the predictive power of HASI 
was restricted to men and to normotensive subjects. Therefore, 
further population studies should be carried out in order to 
establish the predictive significance of HASI.
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